chloroquine has been researched along with antipyrine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (53.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Back, DJ; Breckenridge, AM; Purba, HS | 1 |
| Northover, BJ | 1 |
| Oldendorf, WH | 1 |
| Mayr, E | 1 |
| Dinnendahl, V; Kalbhen, DA | 1 |
| Back, DJ; Orme, ML; Park, BK; Purba, HS; Ward, SA | 1 |
| Back, DJ; Breckenridge, AM; Orme, ML; Purba, HS; Staiger, C | 1 |
| BERNTSEN, K; BOSTROEM, H; WHITEHOUSE, MW | 1 |
1 review(s) available for chloroquine and antipyrine
| Article | Year |
|---|---|
[Antirheumatic drugs. 40].
Topics: Aminopyrine; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimalarials; Antipyrine; Camphor; Chloroquine; Dexamethasone; Esters; Flufenamic Acid; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Indomethacin; Mefenamic Acid; Methylprednisolone; Nicotinic Acids; Oils, Volatile; Oxyphenbutazone; Prednisolone; Prednisone; Rheumatic Diseases; Salicylates; Triamcinolone | 1969 |
14 other study(ies) available for chloroquine and antipyrine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Inhibition of estrogen 2-hydroxylase.
Topics: Animals; Antipyrine; Chloroquine; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A1; Diethylstilbestrol; Estradiol; Ethinyl Estradiol; Imidazoles; Kinetics; Male; Metronidazole; Microsomes, Liver; Primaquine; Rats; Rats, Inbred Strains; Steroid Hydroxylases | 1986 |
The effect of anti-inflammatory drugs on vascular smooth muscle.
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Antipyrine; Benzoates; Bradykinin; Chloroquine; Culture Techniques; Epinephrine; Flufenamic Acid; Guinea Pigs; Histamine H1 Antagonists; Hydrocortisone; Ileum; Indomethacin; Male; Mesenteric Arteries; Mesenteric Veins; Muscle, Smooth; Norepinephrine; Phenylbutazone; Rats; Salicylates; Vas Deferens; Vasoconstrictor Agents | 1967 |
Brain uptake of metabolites and drugs following carotid arterial injections.
Topics: Acetates; Amino Acids; Animals; Antipyrine; Ascorbic Acid; Aspirin; Barbiturates; Blood-Brain Barrier; Brain; Caffeine; Chloroquine; Cyanides; Ethanol; Imipramine; Lactates; Mescaline; Morphine; Neurotransmitter Agents; Nicotine; Penicillin G; Pharmaceutical Preparations; Phenytoin; Procaine; Pyruvates; Rats | 1971 |
[Pharmacology studies on the influencing of chondroitin sulfate decomposition in vitro].
Topics: Aminopyrine; Anti-Inflammatory Agents; Antipyrine; Aspirin; Chemical Phenomena; Chemistry; Chloroquine; Chondroitin; Copper; Densitometry; Flavonoids; Flufenamic Acid; Glucosamine; Hyaluronoglucosaminidase; Iron; Lidocaine; Male; Malonates; Methylamines; Oxyphenbutazone; Prednisolone; Rutin; Sodium Chloride; Sodium Salicylate; Sulfates; Testis; Triazines | 1971 |
Effect of chloroquine and primaquine on antipyrine metabolism.
Topics: Adult; Antipyrine; Chloroquine; Half-Life; Humans; Male; Metabolic Clearance Rate; Primaquine | 1983 |
Inhibition of drug metabolism by the antimalarial drugs chloroquine and primaquine in the rat.
Topics: Aminopyrine N-Demethylase; Animals; Antipyrine; Chloroquine; Kinetics; Male; Paralysis; Pentobarbital; Pharmaceutical Preparations; Primaquine; Rats; Rats, Inbred Strains; Sleep; Time Factors; Zoxazolamine | 1983 |
BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS-II. SOME EFFECTS ON SULPHATE-35S METABOLISM IN VIVO.
Topics: Adenosine Triphosphate; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Antipyrine; Autoradiography; Benzoates; Cartilage; Chloroquine; Chromatography; Dicumarol; Dinitrophenols; Glycosaminoglycans; Hydrocortisone; Inflammation; Kidneys, Artificial; Metabolism; ortho-Aminobenzoates; Oxyphenbutazone; Phenylbutazone; Pyrazoles; Quinolines; Rats; Research; Sodium Salicylate; Sulfates; Sulfinpyrazone; Sulfur Isotopes; Uricosuric Agents; Urine | 1964 |